BIOCRYST PHARMACEUTICALS INC (BCRX) Stock News

USA - Nasdaq - NASDAQ:BCRX - US09058V1035 - Common Stock

7.57 USD

-0.01 (-0.13%)

Last: 12/12/2025, 8:15:25 PM

7.56 USD

-0.01 (-0.13%)

After Hours: 12/12/2025, 8:15:25 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

BCRX Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Stocktwits - Mentions: IWMW VTWG

News Image

Why Are Retail Traders Going Gaga Over BioCryst Pharma Stock Today?

a day ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Announces FDA Approval of ORLADEYO® (berotralstat) Oral Pellets, First and Only Oral Prophylactic Treatment for Patients with HAE Aged 2 to <12 Years

9 days ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 days ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Receives Early Termination of HSR Waiting Period for Astria Acquisition

22 days ago - By: The Motley Fool - Mentions: DYN ACAD ASND RY ...

Why Dyne Therapeutics Stock Was Crushing it This Week

a month ago - By: Astria Therapeutics, Inc. - Mentions: ATXS

Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

2 months ago - By: Stocktwits - Mentions: ATXS

News Image

BioCryst Stock Tumbles On Astria Buyout, But Analysts Stay Bullish — Retail Cheers The Move As Long-Term Play

2 months ago - By: Stocktwits - Mentions: ATXS

News Image

BioCryst To Acquire Astria Therapeutics In $700M Deal

a month ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst to Present at Upcoming Investor Conference

a month ago - By: The Motley Fool

BioCryst (BCRX) Q3 2025 Earnings Call Transcript

a month ago - By: Benzinga - Mentions: SNAP IONQ CGC BLNK ...

Top Stocks With Earnings This Week: Joby, IonQ, AMD and More

4 months ago - By: Zacks Investment Research

Are Options Traders Betting on a Big Move in BCRX Stock?

4 months ago - By: Benzinga

Earnings Outlook For BioCryst Pharma

a month ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update

2 months ago - By: Brodsky & Smith LLC - Mentions: SOHO HOLX ATXS PCH ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sotherly Hotels Inc. (Nasdaq – SOHO), Hologic, Inc. (Nasdaq – HOLX), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH)

2 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst to Present New Pediatric HAE Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting

2 months ago - By: Brodsky & Smith LLC - Mentions: HOLX TRUE PCH RYN ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hologic, Inc. (Nasdaq – HOLX), TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH)

2 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst to Report Third Quarter 2025 Financial Results on November 3

2 months ago - By: Brodsky & Smith LLC - Mentions: TRUE ATXS PCH SWKH ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH), SWK Holdings Corporation (Nasdaq – SWKH)

2 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile

2 months ago - By: Astria Therapeutics, Inc. - Mentions: ATXS

BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile

2 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Completes Sale of European ORLADEYO® (berotralstat) Business

3 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst to Present at Upcoming Investor Conference

4 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Announces Departure of Dr. Helen Thackray

4 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Stocktwits - Mentions: IWMW AVUS

BioCryst Eyes Strengthening Pipeline After Upbeat Q2 Earnings: Retail Thinks Fair Valuation For Stock Is Double The Current Level

4 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Second Quarter 2025 Financial Results and Provides Business Update

5 months ago - By: BioCryst Pharmaceuticals, Inc.

BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December